Price
$287.23
Decreased by -1.01%
Dollar Volume
358.98 M
ADR%
3.55
Earnings Report Date (estimate)
Feb 15, 23 (8.23)
Market Cap.
33.65 B
Shares Float
116.92 M
Shares Outstanding
117.15 M
Beta
1.52
Price / Earnings
21.78
BPR
204.22
20D Range
215.29 291.84
50D Range
208.57 291.84
200D Range
184.34 334.01
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Nov 3, 22 7.50
Increased by +642.57%
6.99
Increased by +7.30%
Nov 2, 22 7.50
Increased by +614.29%
6.99
Increased by +7.30%
Aug 3, 22 3.45
Increased by +287.64%
3.26
Increased by +5.83%
May 4, 22 2.38
Increased by +116.36%
1.63
Increased by +46.01%
Feb 16, 22 1.01
Decreased by -13.68%
0.99
Increased by +2.02%
Nov 3, 21 1.05
Decreased by -10.26%
0.77
Increased by +36.36%
Aug 4, 21 0.89
Decreased by -18.35%
0.84
Increased by +5.95%
May 5, 21 1.10
Increased by +27.91%
0.80
Increased by +37.50%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 2.09 B
Increased by +151.85%
897.22 M
Increased by +328.43%
Increased by +42.89%
Increased by +190.70%
Jun 30, 22 1.48 B
Increased by +91.19%
406.77 M
Decreased by -4.20%
Increased by +27.49%
Decreased by -49.89%
Mar 31, 22 1.13 B
Increased by +35.99%
253.38 M
Increased by +164.83%
Increased by +22.47%
Increased by +94.75%
Dec 31, 21 894.20 M
Increased by +1.71%
-3.82 M
Decreased by -104.52%
Decreased by -0.43%
Decreased by -104.44%
Sep 30, 21 830.57 M
Increased by +11.21%
-392.78 M
Decreased by -499.57%
Decreased by -47.29%
Decreased by -459.30%
Jun 30, 21 773.90 M
Increased by +1.29%
424.60 M
Increased by +395.89%
Increased by +54.87%
Increased by +389.58%
Mar 31, 21 829.29 M
Increased by +12.24%
95.68 M
Decreased by -10.75%
Increased by +11.54%
Decreased by -20.49%
Dec 31, 20 879.15 M
Decreased by -11.43%
84.64 M
Decreased by -6.37%
Increased by +9.63%
Increased by +5.71%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.